ORIC
ORIC
US68622P1093
Oric Pharmaceuticals, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Market & Enterprise Value
Market Cap
1.24B EUR
1.12B EUR
1.31B EUR
Enterprise Value
988.18M EUR
1.09B EUR
1.26B EUR
Valuation Multiples
Trailing P/E
--
--
--
Forward P/E
-7.17x
--
--
Price to Sales
--
--
--
Price to Book
3.26x
2.94x
3.16x
EV/Revenue
--
--
--
EV/EBITDA
-6.38x
--
--
Price to FCF (P/FCF)
--
--
--
EV/FCF
--
--
--
FCF Yield
-5.54%
-10%
-8.48%
ende